Continuing impact of infectious diseases on childhood deaths in England and Wales, 2003-2005

Pediatric Infectious Disease Journal

Volumn 29, Issue 4, 2010, Pages 310-313

  Ladhani, Shamez ^a,b   Pebody, Richard G ^a   Ramsay, Mary E ^a   Lamagni, Theresa L ^a   Johnson, Alan P ^a   Sharland, Mike ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Childhood mortality; Infection; Pathogens; Prevention

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CEREBRAL PALSY; CHILD; CHILD DEATH; CHILDHOOD CANCER; CHILDHOOD MORTALITY; CONTROLLED STUDY; DEATH CERTIFICATE; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INFANT; INFECTION; MALE; MENINGOCOCCOSIS; MYCOSIS; PNEUMOCOCCAL INFECTION; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED KINGDOM; VIRUS INFECTION;

EID: 77950239560     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181d73322     Document Type: Article

References (27)

1. Collison D, Dey C, Hannah G, et al. Income inequality and child mortality in wealthy nations. J Public Health (Oxf). 2007;29:114-117.
2. Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298:2155-2163.
3. Pearson GA, ed. Why Children Die: A Pilot Study 2006; England (South West, North East and West Midlands), Wales and Northern Ireland. London: Confidential Enquiry into Maternal and Child Health (CEMACH); 2008.
4. World Health Organization. International Statistical Classification of Diseases and Related Health Problems: Tenth Revision (ICD-10). 2nd ed. Geneva, Switzerland: World Health Organization; 2005. Available at: http://www.who.int/ classifications/apps/icd/icd10online/.
5. Maudsley G, Williams EM. Inaccuracy in death certification\where are we now? J Public Health Med. 1996;18:59-66.
6. Moriyama IM. Problems in measurement of accuracy of cause-of-death statistics. Am J Public Health. 1989;79:1349-1350.
7. Markov PV, Crowcroft NS. Modelling the unidentified mortality burden from thirteen infectious pathogenic microorganisms in infants. Epidemiol Infect. 2007;135:17-26.
8. Health Protection Agency. National Confidential Study of Deaths Following Meticillin-Resistant Staphylococcus aureus Infection. London: Health Protection Agency; 2007.
9. Wheller L, Rooney C, Griffiths C. Death certification following MRSA bacteraemia, England, 2004-2005. Health Stat Q. 2009;13-20.
10. Lamagni TL, Neal S, Keshishian C, et al. Predictors of mortality following severe Streptococcus pyogenes infection. Emerg Infect Dis. 2009;15:1304-1307.
11. Weber MA, Klein NJ, Hartley JC, et al. Infection and sudden unexpected death in infancy: a systematic retrospective case review. Lancet. 2008;371: 1848-1853.
12. Blackwell C. Bacterial toxins and sudden unexpected death in infancy. Lancet. 2008;372:714.
13. Poehling KA, Edwards KM, Weinberg GA, et al. The under-recognized burden of influenza in young children. N Engl J Med. 2006;355:31-40.
14. Eisenberg KW, Szilagyi PG, Fairbrother G, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics. 2008; 122:911-919.
15. English P. Should universal hepatitis B immunisation be introduced in the UK? Arch Dis Child. 2006;91:286-289.
16. van der Sande MA, Waight P, Mendy M, et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis. 2006; 193:1528-1535.
17. Linhares AC, Velazquez FR, Perez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371:1181-1189.
18. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007; 370:1757-1763.
19. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
20. Grose C. Varicella vaccination of children in the United States: assessment after the first decade, 1995-2005. J Clin Virol. 2005;33:89-95.
21. Pichichero M, Casey J, Blatter M, et al. Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccha-ride-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two-to ten-year-old children. Pediatr Infect Dis J. 2005;24:57-62.
22. Keyserling H, Papa T, Koranyi K, et al. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents. Arch Pediatr Adolesc Med. 2005;159:907-913.
23. Scott DA, Komjathy SF, Hu BT, et al. Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 2007;25: 6164-6166.
24. Giuliani MM, du-Bobie J, Comanducci M, et al. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci USA. 2006;103:10834-10839.
25. Nokes JD, Cane PA. New strategies for control of respiratory syncytial virus infection. Curr Opin Infect Dis. 2008;21:639-643.
26. Pollard AJ. Childhood immunisation: what is the future? Arch Dis Child. 2007;92:426-433.
27. Potz N, Powell D, Lamagni T, et al. Mortality following invasive MRSA infection in England, 2004-5. In: Proceedings of the 17th European Congress of Clinical Microbiology and Infectious Diseases; March 31, 2007; Munich, Germany. Clin Microbiol Infect. 2007;13:S365.